PubMed:32178765 / 0-301 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T1	0-206	Sentence	denotes	Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
T2	207-218	Sentence	denotes	BACKGROUND:
T1	0-206	Sentence	denotes	Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
T2	207-218	Sentence	denotes	BACKGROUND:

Id	Subject	Object	Predicate	Lexical cue
T1	0-10	CI	denotes	Guselkumab
T2	35-54	DP	denotes	psoriatic arthritis
T3	238-257	DP	denotes	psoriatic arthritis
T25	173-180	CI	denotes	placebo

Id	Subject	Object	Predicate	Lexical cue
T1	0-10	CI	denotes	Guselkumab
T4	238-257	DP	denotes	psoriatic arthritis
T5	35-54	DP	denotes	psoriatic arthritis
T19	173-180	CI	denotes	placebo